Post-Rehab Opioid Tolerance & Overdose Safety Planner

Following abstinence or inpatient rehab, μ-opioid receptor sensitivity drops precipitously within days. Calculate realistic receptor desensitization, test adulterant exposure scenarios, and build a discharge safety transition protocol.

Crucial Medical Fact: Overdose death risk is 10 to 16 times higher during the first 2 to 4 weeks post-discharge from abstinence-only rehab or incarceration. Prior tolerance is erased while street fentanyl potency remains extreme.
⚠️

Critical Lethal Overdose Hazard

Severe respiratory depression expected: 28 days of abstinence has depleted opioid tolerance while street fentanyl potency overpowers the medullary drive.

Fatal Index
94 / 100
Receptor Tolerance
14%
of pre-detox capacity
Resp. Drive (BPM)
3.2
normal: 12-18 bpm
Estimated SaO2
68%
arterial hypoxemia
Time to Hypoxia
3.5 min
without reversal
Tolerance Decay Curve & Overdose Lethal Gap
Tolerance Reserve
Exposure Potency
Operating Point

Tailored Discharge Safety Transition Protocol 5 of 5 Actions Advised

  • Co-Prescribe Multiple 4mg Intranasal Naloxone (Narcan) Kits Provide at least two doses directly into the patient's hands upon discharge; educate family/friends on nasal administration.
  • Rapid Bridge to Buprenorphine or Methadone (MOUD) Continuous partial agonist therapy prevents tolerance collapse and occupies 75%+ of μ-receptors, conferring 50%+ reduction in mortality.
  • Establish "Never Use Alone" & Virtual Spotting Protocol Ensure patient has emergency check-in lines (e.g. 1-800-484-3731) and never uses in a locked room where rescue is blocked.
  • Supply Fentanyl & Xylazine Test Strips with Training Illicit street supplies are over 85% contaminated; drug checking provides tangible actionable risk awareness.
  • 72-Hour Post-Discharge Peer Recovery Contact Schedule proactive warm handoff check-ins on Days 1, 3, and 7—the peak window of post-rehab relapse vulnerability.
Scenario evaluated: High risk mitigation plan generated.

Clinical Context: Why Post-Rehab Is the Most Dangerous Period

1. Pharmacokinetics of Rapid Tolerance Loss

During active chronic opioid exposure, μ-opioid receptors undergo profound down-regulation, internalizing receptors and decoupling G-proteins. When intake stops (e.g. during a 28-day rehabilitation or detox stay), receptor density and sensitivity resensitize to a near-naive state within 7 to 14 days. Taking even half of an old habit dose triggers acute massive medullary receptor saturation.

2. The Fentanyl & Synthetics Multiplier

Unlike pharmaceutical morphine or heroin, illicit fentanyl has a high lipophilicity and 50 to 100-fold higher binding affinity. Even a microscopic dosage variation in unregulated street powder exceeds the reduced respiratory threshold of a post-rehab patient within seconds.

3. The Role of MOUD as a Protective Biological Shield

Substance-use treatment facilities that discharge patients without Medications for Opioid Use Disorder (MOUD, like Buprenorphine or Methadone) leave them biologically defenseless. Buprenorphine's tight receptor affinity acts as an antagonist barrier to street opioids while maintaining baseline respiratory tolerance.

4. The "Wooden Chest" & Hypoxia Window

Fentanyl-induced chest wall rigidity ("wooden chest syndrome") can prevent effective chest expansions in under 60 seconds. Having multiple naloxone doses immediately accessible, alongside trained bystanders or remote spotting lines, is the definitive difference between survival and fatality.

Enjoy this tool? Build your own with Super